Featured Research

from universities, journals, and other organizations

Professional surfer back in the water after successful surgery to treat rare bone cancer

Date:
May 13, 2014
Source:
Cedars-Sinai Medical Center
Summary:
When professional surfer Richie Lovett began experiencing hip pain at 31, he attributed it to his athletic lifestyle. But after months of discomfort and preliminary tests, the Australian native learned the pain was caused by a cancerous tumor in his femur or thigh bone. A surgical technique was applied, requiring the removal of Lovett's tumor and damaged bone in its entirety. It was then replaced with a prosthetic and then reconnected his hip and surrounding muscle to the prosthetic implant. This innovative approach provides the greatest range of movement possible.

This is Richie Lovett competing after recovering from cancer surgery.
Credit: Jon Frank

When professional surfer Richie Lovett began experiencing hip pain at 31, he attributed it to his athletic lifestyle. But after months of discomfort and preliminary tests, the Australian native learned the pain was caused by a cancerous tumor in his femur or thigh bone.

"As a professional athlete, I was blindsided by the news that I had cancer," said Lovett. "I realized very quickly that cancer would have a profound effect on my life. I knew I needed an experienced oncologist to tackle this disease, so I began an international search to find the very best options and care."

The search led him from Australia to the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and the care of surgical oncologist Earl Warren Brien, MD.

Brien, director of Musculoskeletal Tumor Service at the Orthopaedic Oncology Program in the Cedars-Sinai Orthopaedic Center and a lifelong surfer himself, is an expert in treating bone cancer and has pioneered many of the most groundbreaking surgical procedures in orthopedic oncology, one of which would benefit Lovett.

Brien diagnosed Lovett with a tumor called clear cell chondrosarcoma, an uncommon form of bone cancer that rarely responds to chemotherapy or radiation. Instead of therapeutic treatments, Lovett would undergo a state-of-the-art surgery to give him the best chance at surfing again.

The surgical technique, described recently in the journal Orthopedics, required Brien to remove Lovett's tumor and damaged bone in its entirety, replace it with a prosthetic and then reconnect his hip and surrounding muscle to the prosthetic implant. This innovative approach provides the greatest range of movement possible.

With standard procedures, healing can be slow and patients often need multiple follow-up surgical procedures. But when damaged bone is removed and replaced with a metal prosthesis, patients may get back to their daily activities more quickly and easily, Brien said.

"The surgical approach Richie received is unique due to the prosthetic," said Brien. "The prosthesis is made of a combination of cobalt-chrome and titanium and has a three-piece head that allows for more range of motion and greater stability. This technique gave Richie, and patients like him, a faster recovery, more predictable outcomes and better overall quality of life."

Eight years later, Lovett is free from the rare bone cancer and back in the water, surfing and enjoying a full life with his two young children and wife.

"I am committed to staying healthy and living a positive life," said Lovett. "I influence people wherever I can and am forever grateful to Dr. Brien for getting me back into the water."


Story Source:

The above story is based on materials provided by Cedars-Sinai Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Muhammad Umar Jawad, Earl W. Brien. Proximal Femoral Reconstruction With a Constrained Acetabulum in Oncologic Patients. Orthopedics, 2014; 37 (2): e187 DOI: 10.3928/01477447-20140124-24

Cite This Page:

Cedars-Sinai Medical Center. "Professional surfer back in the water after successful surgery to treat rare bone cancer." ScienceDaily. ScienceDaily, 13 May 2014. <www.sciencedaily.com/releases/2014/05/140513091121.htm>.
Cedars-Sinai Medical Center. (2014, May 13). Professional surfer back in the water after successful surgery to treat rare bone cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/05/140513091121.htm
Cedars-Sinai Medical Center. "Professional surfer back in the water after successful surgery to treat rare bone cancer." ScienceDaily. www.sciencedaily.com/releases/2014/05/140513091121.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins